ghk-cu bienfaits The Risks of Using Peptides in Wellness Trends GHK-CU PEPTIDE HAIR + SCALP

Dose Community protocols range from 2-5 mg/kg

However, injection is not without drawbacks

Long-term, unmonitored use might also lead to lowered zinc levels

Substantial pharmaceutical research base, including FDA approval for HIV-associated lipodystrophy (under the brand name Egrifta in pharmaceutical formulation)

Systematic site rotation also reduces the risk of localised lipodystrophy (changes in fat distribution) and the development of persistent lumps or subcutaneous nodules at frequently used injection points

Notably, AOD 9604 promotes lipolysis on adipose (fat) tissue without having a negative effect on muscle mass or growth potential of the consumer